12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (TA1045)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 March 2025
Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus (MIB5)Product type:AdviceProgramme:Medtech innovation briefingPublished: 10 June 2014
Ambu aScope 4 RhinoLaryngo for visualising upper airways during rhinolaryngoscopy (MIB316)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 February 2023
Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen (TA1087)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 August 2025
Cochlear implants for children and adults with severe to profound deafness (TA566)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 7 March 2019
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (TA139)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 20 August 2021Published: 26 March 2008
Depemokimab for treating chronic rhinosinusitis with nasal polyps in adults (terminated appraisal) (TA1123)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 January 2026
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA648)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 September 2020
Hearing loss in adults: assessment and management (NG98)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 21 June 2018
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA847)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 November 2022
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA678)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 February 2021
Otitis media (acute): antimicrobial prescribing (NG91)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 March 2022Published: 28 March 2018
Otitis media with effusion in under 12s (NG233)Product type:GuidanceProgramme:NICE guidelinePublished: 30 August 2023
Otovent nasal balloon for otitis media with effusion (MIB59)Product type:AdviceProgramme:Medtech innovation briefingPublished: 15 March 2016
PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)Product type:AdviceProgramme:Medtech innovation briefingPublished: 9 February 2021
Rapid tests for group A streptococcal infections in people with a sore throat (HTG531)Product type:GuidanceProgramme:HealthTech guidancePublished: 13 November 2019
Sinusitis (acute): antimicrobial prescribing (NG79)Product type:GuidanceProgramme:NICE guidelinePublished: 27 October 2017
Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal) (TA972)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 27 January 2026Published: 22 May 2024
Sore throat (acute): antimicrobial prescribing (NG84)Product type:GuidanceProgramme:NICE guidelinePublished: 26 January 2018
SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea (MIB190)Product type:AdviceProgramme:Medtech innovation briefingPublished: 9 September 2019
Tinnitus: assessment and management (NG155)Product type:GuidanceProgramme:NICE guidelinePublished: 11 March 2020
TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum (MIB134)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 January 2018
XprESS multi sinus dilation system for treating chronic sinusitis (HTG424)Product type:GuidanceProgramme:HealthTech guidancePublished: 13 December 2016